Central venous catheter–related thrombosis
- 5 December 2014
- journal article
- review article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2014 (1), 306-311
- https://doi.org/10.1182/asheducation-2014.1.306
Abstract
Thrombotic complications associated with the use of central venous catheters (CVCs) are common and lead to distressing patient symptoms, catheter dysfunction, increased risk of infections, long-term central venous stenosis, and considerable costs of care. Risk factors for catheter-related thrombosis include use of larger, multilumen, and peripherally inserted catheters in patients with cancer receiving chemotherapy. Symptomatic catheter-related thrombosis is treated with anticoagulation, generally without removing the catheter. The intensity and duration of anticoagulation depend on the extent of thrombosis, risk of bleeding, and need for continued use of a CVC. To date, the clinical benefit of prophylactic doses of anticoagulant has been disappointing and these agents are not used routinely for this purpose. This chapter focuses on recent evidence, remaining controversies, and practical approaches to reducing the burden of thrombosis associated with CVCs.Keywords
This publication has 42 references indexed in Scilit:
- Nonleg Venous Thrombosis in Critically Ill AdultsJAMA Internal Medicine, 2014
- Diagnosis and management of upper extremity deep-vein thrombosis in adultsThrombosis and Haemostasis, 2012
- The Effect of Catheter to Vein Ratio on Blood Flow Rates in a Simulated Model of Peripherally Inserted Central Venous CathetersChest, 2011
- Catheter-Associated Thrombosis in Patients With MalignancyJournal of Clinical Oncology, 2009
- Early and short-term acenocumarine or dalteparin for the prevention of central vein catheter-related thrombosis in cancer patients: a randomized controlled study based on serial venographiesAnnals Of Oncology, 2009
- Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trialThe Lancet, 2009
- Jugular Vein Catheter Placement: Histologic Features and Development of Catheter-related (Fibrin) Sheaths in a Swine ModelRadiology, 2006
- Deep vein thrombosis associated with central venous catheters – a reviewJournal of Thrombosis and Haemostasis, 2005
- Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With CancerJournal of Clinical Oncology, 2005
- Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosisInternal Medicine Journal, 2002